Terapia Intensiva

Decisão do consenso de especialistas da ACC de 2022 sobre sequelas cardiovasculares de COVID-19 em adultos: miocardite e outros envolvimentos miocárdicos, sequelas pós-agudas da infecção pelo SARS-CoV-2 e volta aos esportes.

17 Mar, 2022 | 13:25h

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Comentários:

ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology

ACC Releases Guidance on CV Issues With COVID-19 – TCTMD

Pontos principais: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19

Conteúdos relacionados:

Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

Comentário no Twitter (fio – clique para saber mais)

Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem

— American College of Cardiology (@ACCinTouch) March 16, 2022

Evidências Cochrane | Tratamento para COVID-19 moderada a grave.

17 Mar, 2022 | 13:22h

Treatments for moderate to severe COVID-19: Cochrane evidence – Evidently Cochrane

Hipertensão maligna: perspectivas atuais e desafios.

17 Mar, 2022 | 13:12h

Malignant Hypertension: Current Perspectives and Challenges – Journal of the American Heart Association

Estudo multicêntrico e aberto sobre acetato de flecainida em solução de inalação oral para conversão aguda de fibrilação atrial sintomática de início recente para ritmo sinusal.

17 Mar, 2022 | 13:11h

Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm – Circulation: Arrythmia & Electrophysiology

Comentário no Twitter

Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonth https://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM

— CircEP (@CirculationEP) February 25, 2022

M-A | Papel da hipercapnia aguda sobre a mortalidade e a fisiologia de curto prazo em pacientes sob ventilação mecânica por síndrome da angústia respiratória aguda (SARA).

17 Mar, 2022 | 12:48h

The role of acute hypercapnia on mortality and short-term physiology in patients mechanically ventilated for ARDS: a systematic review and meta-analysis – Intensive Care Medicine (gratuito por tempo limitado)

Comentário no Twitter

Acute hypercapnia in #ARDS pts on MV, SR/MA.
Conflicting effect! Protective effects of permissive hypercapnia seem driven by associated PV (improved hemodynamics) vs deleterious effects of imposed hypercapnia seem mediated by pulmonary vascular dysfunctionhttps://t.co/H1TuliectW pic.twitter.com/uLoAZPvbWg

— Intensive Care Medicine (@yourICM) March 16, 2022